375 related articles for article (PubMed ID: 16504929)
21. Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.
Börner C; Höllt V; Sebald W; Kraus J
J Leukoc Biol; 2007 Jan; 81(1):336-43. PubMed ID: 17041005
[TBL] [Abstract][Full Text] [Related]
22. Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase.
Takeda S; Yamamoto I; Watanabe K
Toxicology; 2009 May; 259(1-2):25-32. PubMed ID: 19428940
[TBL] [Abstract][Full Text] [Related]
23. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
[TBL] [Abstract][Full Text] [Related]
25. Fungal biotransformation of cannabinoids: potential for new effective drugs.
Saxena S
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):305-12. PubMed ID: 19333876
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
27. Delta 9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events.
Fischer-Stenger K; Dove Pettit DA; Cabral GA
J Pharmacol Exp Ther; 1993 Dec; 267(3):1558-65. PubMed ID: 8263818
[TBL] [Abstract][Full Text] [Related]
28. Determination of the relative percentage distribution of THCA and Δ(9)-THC in herbal cannabis seized in Austria - Impact of different storage temperatures on stability.
Taschwer M; Schmid MG
Forensic Sci Int; 2015 Sep; 254():167-71. PubMed ID: 26247127
[TBL] [Abstract][Full Text] [Related]
29. The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway.
Herrera B; Carracedo A; Diez-Zaera M; Gómez del Pulgar T; Guzmán M; Velasco G
Exp Cell Res; 2006 Jul; 312(11):2121-31. PubMed ID: 16624285
[TBL] [Abstract][Full Text] [Related]
30. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
[TBL] [Abstract][Full Text] [Related]
31. Medicinal cannabis extracts for the treatment of multiple sclerosis.
Smith PF
Curr Opin Investig Drugs; 2004 Jul; 5(7):727-30. PubMed ID: 15298068
[TBL] [Abstract][Full Text] [Related]
32. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.
Ozaita A; Puighermanal E; Maldonado R
J Neurochem; 2007 Aug; 102(4):1105-14. PubMed ID: 17484726
[TBL] [Abstract][Full Text] [Related]
33. (+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only.
Fride E; Feigin C; Ponde DE; Breuer A; Hanus L; Arshavsky N; Mechoulam R
Eur J Pharmacol; 2004 Dec; 506(2):179-88. PubMed ID: 15588739
[TBL] [Abstract][Full Text] [Related]
34. Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.
Stadelmann AM; Juckel G; Arning L; Gallinat J; Epplen JT; Roser P
Neurosci Lett; 2011 May; 496(1):60-4. PubMed ID: 21513772
[TBL] [Abstract][Full Text] [Related]
35. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol.
Buchweitz JP; Karmaus PW; Williams KJ; Harkema JR; Kaminski NE
J Leukoc Biol; 2008 Mar; 83(3):785-96. PubMed ID: 18073275
[TBL] [Abstract][Full Text] [Related]
36. The role of the CB1 receptor in the regulation of sleep.
Murillo-Rodríguez E
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1420-7. PubMed ID: 18514375
[TBL] [Abstract][Full Text] [Related]
37. On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).
Costa B
Chem Biodivers; 2007 Aug; 4(8):1664-77. PubMed ID: 17712813
[TBL] [Abstract][Full Text] [Related]
38. Direct NMR analysis of cannabis water extracts and tinctures and semi-quantitative data on delta9-THC and delta9-THC-acid.
Politi M; Peschel W; Wilson N; Zloh M; Prieto JM; Heinrich M
Phytochemistry; 2008 Jan; 69(2):562-70. PubMed ID: 17964620
[TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
[TBL] [Abstract][Full Text] [Related]
40. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A
Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]